Gregory Scott Duncan - 27 Jun 2025 Form 4 Insider Report for Dogwood Therapeutics, Inc. (DWTX)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Greg Duncan
Issuer symbol
DWTX
Transactions as of
27 Jun 2025
Transactions value $
$0
Form type
4
Filing time
01 Jul 2025, 14:00:33
Previous filing
22 Jan 2025
Next filing
18 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Duncan Gregory Scott CHIEF EXECUTIVE OFFICER, Director C/O DOGWOOD THERAPEUTICS, INC., 44 MILTON AVENUE, ALPHARETTA /s/ Greg Duncan 01 Jul 2025 0001831127

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DWTX Stock Option (right to buy) Award $0 +40K $0.00 40K 27 Jun 2025 Common Stock 40K $4.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests one-third on June 27, 2026 and 1/24th monthly thereafter.